home / stock / xvipf / xvipf short
Short Information | Xvivo Perfusion Ab Ord (OTCMKTS:XVIPF)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 3,140 |
Total Actual Volume | 3,345 |
Short Trends | |
---|---|
Cover Days | 0 |
Short Days | 20 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 157 |
Average Short Percentage | 97.04% |
Is there a XVIPF Short Squeeze or Breakout about to happen?
See the XVIPF Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
05-06-2024 | $35.025 | $35.07 | $35.07 | $35.025 | 405 | 300 | 74.07% |
05-02-2024 | $34.01 | $34.01 | $34.01 | $34.01 | 100 | 100 | 100% |
04-30-2024 | $0 | $32.2 | $0 | $0 | 11 | 11 | 100% |
04-25-2024 | $32.2 | $32.2 | $32.2 | $32.2 | 130 | 130 | 100% |
04-24-2024 | $33.53 | $33.53 | $33.53 | $33.53 | 100 | 100 | 100% |
04-23-2024 | $29.48 | $29.48 | $29.48 | $29.48 | 100 | 100 | 100% |
04-19-2024 | $29.51 | $29.51 | $29.51 | $29.51 | 100 | 100 | 100% |
04-02-2024 | $0 | $26.38 | $0 | $0 | 75 | 75 | 100% |
04-01-2024 | $26.38 | $26.38 | $26.38 | $26.38 | 700 | 700 | 100% |
03-27-2024 | $26.095 | $26.095 | $26.095 | $26.095 | 100 | 100 | 100% |
03-26-2024 | $0 | $26.37 | $0 | $0 | 5 | 5 | 100% |
03-22-2024 | $26.37 | $26.37 | $26.37 | $26.37 | 100 | 100 | 100% |
03-21-2024 | $27.05 | $27.05 | $27.05 | $27.05 | 100 | 100 | 100% |
03-05-2024 | $26.1 | $26 | $26.1 | $26 | 300 | 200 | 66.67% |
02-29-2024 | $26.08 | $26.22 | $26.22 | $26.08 | 200 | 200 | 100% |
02-26-2024 | $25.58 | $25.715 | $25.715 | $25.58 | 491 | 491 | 100% |
02-12-2024 | $0 | $27.7 | $0 | $0 | 28 | 28 | 100% |
01-31-2024 | $28.44 | $28.44 | $28.44 | $28.44 | 100 | 100 | 100% |
01-26-2024 | $27.63 | $27.63 | $27.63 | $27.63 | 100 | 100 | 100% |
01-25-2024 | $27.8 | $27.8 | $27.8 | $27.8 | 100 | 100 | 100% |
News, Short Squeeze, Breakout and More Instantly...
Xvivo Perfusion Ab Ord Company Name:
XVIPF Stock Symbol:
OTCMKTS Market:
GOTHENBURG, SWEDEN / ACCESSWIRE / April 24, 2024 / XVIVO Perfusion AB (STO:XVIVO) (LSE:0RKL)(FRA:3XV) First quarter 2024 (Jan 1 - Mar 31) • Net sales amounted to SEK 186.0 million (140.6), corresponding to an increase of 32 percent in SEK and equivalent increase, 32 percent, adjusted ...
GOTHENBURG, SWEDEN / ACCESSWIRE / April 11, 2024 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) Today, at the 2024 International Society of Heart and Lung Transplantation meeting in Prague, Czech Republic, the results from XVIVO's clinical trial, NIHP2019, in heart transplantation were pres...
GOTHENBURG, SWEDEN / ACCESSWIRE / April 4, 2024 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) Today XVIVO Perfusion AB (publ) publish the Annual Report for 2023. The Annual Report is attached to this press release in pdf format and in ESEF format (European Single Electronic Format) and is...